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Scintigraphic Detection of Bone and Joint 
Infections with Indium-111 -Labeled 
Nonspecific Polyclonal Human 
Immunoglobulin G
W im J.G. Oyen, Roland A.M.J. Claessens, Jim  R. van Horn, Jos W.M. van der Meer, and 
Frans H.M. Corstens
University Hospital Nijmegen, Departments o f  Nuclear Medicine, Orthopaedics and Internal Medicine, University o f  
Nijmegen, The Netherlands
The utility of indium-111- (111ln) labeled immunoglobulin G 
(IgG) to detect infection of bone and adjacent tissues was 
investigated. Proof of infection was obtained by cultures 
taken at surgery. All 32 patients showed focally increased 
uptake on the technetium-99m- (99mTc) methylene diphos­
phonate (MDP) skeletal scintigraphies. Labeled immuno­
globulin correctly identified presence, location, extent and 
soft-tissue involvement of the suspected inflammatory site. 
In these patients, focally increasing accumulation was 
noted over 48 hr. Discrimination between infection and 
sterile inflammatory lesions was not possible. Two frac­
tures, 6-mo-old, and an aseptic loosening of a total-hip 
prosthesis were not visualized. Side effects after the im­
munoglobulin administration were not observed. Radio- 
labeled immunoglobulin is a new and safe radiopharma­
ceutical for the investigation of infectious bone and joint 
disease. The sensitivity of this agent appears at least as 
high as that of labeled leukocytes. However, labeled im­
munoglobulin can easily be prepared in every nuclear 
medicine department.
J Nucl Med 1990; 31:403-412
In fe c t io n s  of bone and adjacent tissues often present 
a diagnostic and therapeutic problem, making the m an­
agement of the disease difficult. The available scinti­
graphic imaging techniques show limitations in diag­
nosing these infections. This applies especially to pa­
tients who have undergone multiple revision operations 
for chronic osteomyelitis. Technetium-99m-methylene 
diphosphonate (giimTc-MDP) bone imaging is nonspe­
cific and not suitable to demonstrate the extent of the 
lesion accurately (1-3). Gallium-67 (67Ga) may accu-
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muíate in areas of increased bone turnover and shows 
modest accumulation compared to indium -111- (111 In) 
labeled nonspecific polyclonal human immunoglobulin 
G (IgG) (2,4,5). Some authors reported a low sensitivity 
o f 11 'In-labeled white blood cells (WBC) scintigraphy to 
detect low-grade infection (2,6). The utility of ^ mTc- 
WBC to detect chronic osteomyelitis has not been 
established. Above this, time-consuming techniques are 
required for every WBC labeling method ( 7,8). Labeling 
of leukocytes in full blood with ,,gmTc-colloid has not 
been sufficiently validated yet (9-11).
Recently, several reports have appeared suggesting 
the potential utility o f 11 'In-IgG as an imaging agent for 
detecting focal inflammation. These studies, both in 
animals and humans have been primarily concerned 
with soft-tissue, intraabdominal, and vascular infection 
(4,12-14). Because of the need for better techniques for 
imaging bone and joint infection, we initiated a study 
to evaluate the safety and accuracy of IgG scintigraphy 
in patients with infections of bone and adjacent tissue.
MATERIALS AND METHODS 
Radiopharmaceuticals and Imaging Procedures
In all patients routine  three-phase skeletal scintigraphy was 
performed after i.v. injection o f  600 MBq WmT c-M D P.
Diethylenetr iaminepentaacetic  bicyclic anhydride  (bicy- 
clic D TPA) was conjugated to hum an ,  nonspecific, polyclonal 
IgG (Sandoglobulin, Sandoz AG, Nuernberg. F R G ) according 
to Hnatowich and colleagues (15). The purified D TPA -con- 
jugated IgG was diluted to 5 m g /m l  with 0.15 M  acetate (pH 
=  6.5) and sterilized by m em brane  filtration. Aliquots o f  0.5 
ml o f  the conjugate were radiolabeled with 11'In (Ind ium  
chloride, A m ersham  International Ltd., Buckinghamshire, 
U K ) via citrate transchelation. The  radiochemical purity was 
determ ined  by ITLC-SG chrom atography  (G elm an  Labora­
tories, Ann Arbor, MI) with 0.1 M  citrate (pH =  5) as the 
solvent. The labeling efficiency was always higher than  97%. 
A dose o f  ~1 mg o f  IgG labeled with 75 MBq 11'In was 
injected intravenously either between 2 and  7 days after the
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99nT c - M D P  skeletal scintigraphy had been com pleted ,  or  after 
the second-phase images o f  'MmT c -M D P  scintigraphy were 
obtained. The  latter procedure  was followed when operation 
was scheduled within 72 hr after the patient had been referred 
to the nuclear medicine depar tm en t .  Scintigraphic images 
were obtained with a Siemens O rbiter  g a m m a  cam era  c o n ­
nected to a Scintiview image processor (Siemens Inc., Des 
Plaines, IL). All images were collected in digital form at in a 
256 X 256 matrix. Bone images w'ere always obtained with a 
low-energy parallel-hole co ll im ator  ( 140 keV photopeak ,  15% 
sym m etric  window). However, when '" In - Ig G  was injected 
after the second phase o f  the skeletal scintigraphy, the delayed 
bone images were obtained with a m edium -energv  parallel- 
hole coll im ator (140 keV photopeak ,  15% sym m etr ic  w in­
dow). I n d iu m - 111 -IgG images were acquired at 4, 18-24, and 
4 2 -4 8  hr postinjection for a preset t ime o f  5, 7.5, and  10 min, 
respectively. A pproxim ate ly  1 .000-1 .500K  cts for the t runk  
region, 6 0 0 -7 5 0 K  cts for the pelvic region and  8 0 -1 2 0 K  cts 
for the lower l imb were collected. A m edium -energy  parallel- 
hole coll im ator (173 keV peak, 15% sym m etr ic  window; 247 
keV peak, 15% sym m etr ic  window) w-as used. W hen  injected 
after the second phase o f  the bone scan, the 173-keV 11'In 
peak was not used for imaging " ' In - Ig G  4 and  18-24 hr 
postinjection.
All images w-ere interpreted by three observers. T he  observ­
ers were not blinded for clinical in form ation  or radiographic 
images, when available. A definite ju d g em en t  o f  the scinti­
graphic images was reached before any o f  the verification 
procedures were performed. T he  '" In - Ig G  images were inter­
preted with the corresponding  bone scintigraphy. An ' " I n -  
IgG scan was interpreted as positive, if  focal increasing  accu­
m ulation  could be noted over time. Nonvisualization o f  the 
lesion detected by bone scan a n d /o r  plain radiograph, or 
failure to show increasing accum ula t ion  was considered to be 
a negative '" In - Ig G  scintigraphy.
Patients
Patients suspccted o f  acute (evidence o f  infection since one 
or several days) or chronic  (evidence o f  infection for weeks, 
m on ths  or even years) osteomyelitis or  infectious arthritis  in 
w hom  a il,mT c -M D P  bone scan was indicated and in w hom  
proof  o f  the infection was likely to be obtained, were eligible 
for the study. In 22 out o f  25 patients suspected o f  infection, 
cultures from the focus were obtained within two days after 
com pletion  o f  the imaging procedures, e ither during  operation 
or by needle aspiration. Fur therm ore ,  a small n u m b e r  o f  
patients with noninfectious bone disease were studied to get 
an impression o f  the specificity o f  11 'In-IgG scintigraphy. O ne 
patient with clinically-cured sternal osteomyelitis was studied. 
If the a t tending  physician agreed to perform " ' In - Ig G  scintig­
raphy. patients were informed about the experim ental  nature  
o f  the imaging procedure. Pregnant and lactating females were 
excluded from the study. N o patient had a history suggestive 
o f  IgA- or IgG-deficiency or adverse reaction to previous IgG 
adm inistra tion . Informed consent was obtained. The  study 
was approved by the local ethical com m ittee .
Other Procedures
Blood samples were taken from all patients immediate ly  
before and, if possible, 2 -3  wk after the '" In - Ig G  injection for 
extensive hematologic (full-blood cell coun t  and  W BC differ­
entia tion) and  biochemical (minerals,  liver and kidney func­
tion, glucose, cholesterol, protein spectrum ) assessment. Also 
qualitative urinalysis was performed. Vital signs were m o n i ­
tored up to 45 m in  after injection.
In five patients, suspected o f  infectious bone  disease, the 
relative up take  o f  " ' I n - Ig G  in the focus com pared  to the 
uptake in the contralateral l imb was estimated after drawing 
variable size regions o f  interest (ROI) on the 4 2 -4 8 -h r  images. 
Similar regions were then draw n over the corresponding  areas 
on the 4- and 18-24-hr  images. Before calculating the ratios 
on the consecutive images, the regions were norm alized  for 
slight differences in size o f  the two regions.
T he  sam e procedure  was followed for calculating the ratios 
in five patients  suffering from noninfectious  bone  disease. In 
case o f  nonvisualization o f  a lesion by 1 " In -IgG , the p lacem ent  
o f  the region was guided by the area o f  increased uptake  on 
the skeletal scintigraphy.
In three patients, a series o f  blood samples were taken after 
'" In - Ig G  injection in o rder  to est im ate  the blood clearance o f  
" ' In - Ig G .
RESULTS
Thirty-two patients (16 males, 16 females; mean age 
52.7 yr, range 23-87 yr) were investigated. Twenty-five 
patients were suspected of bone and joint infections in 
29 lesions. Seven patients were suffering from nonin­
fectious bone and adjacent tissue disease.
The clinical characteristics of the investigated pa­
tients, the results of the ‘"In-IgG scintigraphy, the 
verification procedure, and the results of the microor­
ganism cultures are summarized in Tables 1-4. The 
patients are categorized on the basis of the clinical data 
available to the observers at the time of imaging. Sinus 
tract cultures are not included in Table 1 because they 
may not reflect the causative microorganism involved
U6).
Clinical or biochemical side effects of the '"In-IgG  
administration were not encountered.
In all 32 patients, the 99mTc-M DP skeletal scintigra­
phy was positive, indicating the site of the skeletal 
lesions. On the basis of the clinical features, the three- 
phase bone scan and the plain radiographs, it was 
possible to make the diagnosis of acute osteomyelitis or 
infectious arthritis with sufficient confidence. However, 
in cases of chronic osteomyelitis, bone scan and radio­
graphs could not identify the presence, the degree, and 
the extent of infection.
Indium -111 -IgG identified the 29 sites of inflamma­
tion in all 25 patients, suspected of having an infection. 
Moreover, with " 'In-IgG scintigraphy, we were able to 
discriminate between osseous and joint infection. The 
involvement of the adjacent soft tissues could be delin­
eated accurately with help of the ggmTc-M DP images. 
Figures 1, 2, 3, and 4 show the images obtained by 
l,l,mTc-MDP and ‘"In-IgG in four patients. In Figures 1 
and 2, plain radiographs also are presented. In case of 
inflammation, in the first 48 hr a relative increase of
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TABLE 1
Clinical Characteristics: Results of the 1111n-IgG Scintigraphy, Verification Procedures, and Culture Results of the
Patients Suspected of Chronic Osteomyelitis
Patient IgG- Verification
(sex, age) History imaging procedure Culture’
1 (F, 38) Low-grade infection after osteosynthesis for 
femoral fracture
+ Operation SA, B, P, 
PA, HS
2 (M, 30) Low-grade infection after complicated tibial 
fracture
+ Operation P, PA, E
3 (M, 81) Total-hip arthroplasty, painful loosening + Operation SA, SE, PA
4 (F, 23) Complicated crural fracture at the age of 6; 
infection since elongation procedure 
lower limb 1 yr prior to scintigraphy
+ Operation SA, D, HS
5 (M, 29) Osteotomy femur, painful hip + Operation SA
6 (F, 27) Low-grade infection after osteosynthesis for 
tibial plateau fracture
+ Operation SA, SE
7 (M, 61) Recurrent low-grade osteomyelitis distal fe­
mur
+ Operation SA
8 (M, 79) Painful loosening total-knee prosthesis + Operation P
9 (M, 63) Painful loosening total-hip prosthesis, fistula + Operation SA
10 (F, 63) Painful loosening total knee prosthesis + Operation D
11 (M, 58) Chronic osteomyelitis after osteosynthesis 
for traumatic pelvic fracture
+ Operation SA
12 (M, 40) Chronic osteomyelitis upper arm with fistula 
after chemotherapy for testiscarcinoma
+ Operation SA
13 (F, 28) Postoperative chronic osteomyelitis ankle + Operation SA, A
14 (F, 85) Postoperative chronic osteomyelitis knee + Operation SA
15 (F, 75) Chronic osteomyelitis humerus + Operation SA
16 (M, 39) Post-traumatic low-grade tibial infection + Fistula n.d.
17 (F, 38) Postoperative recurrent, low-grade infection 
hip
+ Fistula n.d.
18 (M, 32) Chronic osteomyelitis after complicated 
femoral fracture
+ Fistula n.d.
The patients are categorized on the basis of the clinical data available to the observers at the time of imaging. The patients were 
not using antibiotics unless stated.
' A = alcalignes species; B = bacteroides species; D = diphteroid rods; E = enterococcus; HS = hemolytic streptococcus; n.d. = 
not done; M = mycobacterium tuberculosis; P = peptostreptococcus; PA = pseudomonas aeruginosa; SA = staphylococcus aureus; 
and SE = staphylococcus epidermidis.
TABLE 2
Clinical Characteristics: Results of the 111ln-lgG Scintigraphy, Verification Procedures, and Culture Results of the







19 (M, 58) Recurrent staphylococcal bacteriaemia, spondylodiscitis 
thoracic spine. For 1 wk Flucloxacillin 3 g and Genta­
mycin 160 mg daily
+ Autopsy1 SA
20 (M, 43) Possible osteomyelitis after biopsy ilium for a chondro­
sarcoma
+ Operation Negative
21 (F, 66) Acute spondylodiscitis thoracic spine, painful hip + Open biopsy HS
22 (F, 79) Acute spondylodiscitis lumbar spine, painful knee and 
shoulder. For 1 mo: Isoniazide 250 mg, Rifampicin 




Patients are categorized on the basis of the clinical data available to the observers at the time of imaging. Patients were not using 
antibiotics unless stated.
' See Table 1 for definitions.
1 Patient died of cardiorespiratory failure due to a pre-existing heart condition.
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TABLE 3
Clinical Characteristics: Results o f 1111n-IgG Scintigraphy, Verification Procedures, and Culture Results in Patients





21 (F, 66)1 Acute spondylodiscitis thoracic spine, painful 
hip
+ Open biopsy HS
22 (F, 79)r Acute spondylodiscitis lumbar spine, painful 
knee and shoulder. For 1 mo: Isoniazide 
250 mg, Rifampicin 400 mg and Pyrazin- 
amide 1500 mg daily
+ Needle aspiration M
23 (M, 60) Staphylococcal bacteriaemia, painful shoul­
der and upper part of leg. For 2 wk Flu­
cloxacillin 12 g i.v. daily
+ Operation SA
24 (F, 27) Progressively painful shoulder + Operation SA
25 (F, 87) Painful knee, possible arthritis + Needle aspiration Negative
Patients are categorized on the basis of clinical data available to the observers at the time of imaging. Patients were not using 
antibiotics unless stated.
’ See Table 1 for definitions.
1 Patients 21 and 22 were also listed under suspected of acute osteomyelitis/spondylosiscitis.
"'In-IgG activity was noted at the affected site com­
pared to the same region in the contralateral limb. 
Figure 5 shows the increasing ratio of activity over time 
in five individual patients with infection.
In 22 out of 25 patients suspected of infection, cul­
tures from the focus were obtained two days after 
completion of the imaging procedures. In 20 out of 
these 22 patients (Nos. 1-15, 19, 21-24), a positive 
culture was obtained, proving the infectious etiology of 
their disease (15 patients with chronic osteomyelitis, 2 
with acute spondylodiscitis and arthritis, 1 with acute 
spondylodiscitis, and 2 with acute arthritis).
In two patients (Nos. 20 and 25) with positive '" In -  
IgG scans, the cultures were negative. Patient 20 showed
clinical evidence of infection after a biopsy, taken from 
the right ilium because of a chondrosarcoma. The '" In -  
IgG scintigraphy showed increased activity near the site 
of the biopsy. At surgery, a large hematoma was found 
near the biopsy site. Cultures taken at surgery remained 
sterile. The location of the hematoma matched with the 
site of the " 'In-IgG accumulation. In Patient 25 with 
'"In-IgG accumulation in the left knee, joint fluid 
cultures remained sterile. The Gram-stain, however, 
showed marked leucocytosis. The patient was diagnosed 
as having a sterile synovitis of the left knee and re­
covered without further therapy.
At surgery, it appeared that '"In-IgG correctly iden­
tified the presence and localization of the site of inflam-
TABLE 4
Clinical Characteristics: Results o f 111 In-IgG Scintigraphy, Verification Procedures, and Culture Results in Patients







26 (M, 62) Silent rheumatoid arthritis, sudden onset pain 
tibia three weeks ago, stressfracture
+ Open biopsy
27 (M, 23) Recent (10 days) traumatic non-complicated 
tibial fracture
+ No surgery
28 (F, 57) Approximately 6-mo-old fracture pubic bone — No surgery
29 (F, 84) Approximately 6-mo-old fracture around fe­
moral component total hip arthroplasty
No surgery
30 (M, 36) Soft-tissue tumour upper leg (haemangioma) — Operation
31 (F, 51) Post-mediastinoscopy sternal osteomyelitis, 
clinically cured for 3 mo
No surgery
32 (F, 64) Total-hip prosthesis both hips, pain right hip 
region since 6 mo, loosening, no evidence 
of infection
Operation Negative
Patients are categorized on the basis of clinical data available to the observers at the time of imaging. Patients were not using 
antibiotics unless stated.
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FIGURE 1
Patient 4 (23-yr-old female). 
Complicated left crural frac­
ture at age of 6, elongation 
procedure lower leg at age of 
19 (fibular transplant), non­
complicated refracture at age 
of 21, osteomyelitis since os­
teosynthesis. Surgery con­
firmed chronic osteomyelitis. 
Cultures showed growth of 
Staphylococcus aureus and 
epidermidis and beta-hemo- 
lytic Streptococcus. Techne- 
tium-99m-MDP 3 hr postin­
jection (A) and 1111n-IgG 4 (B), 
24 (C), 48 (D) hr postinjection, 





Patient 5 (29-yr-old male). 
Femoral fracture at age of 
15, elongation osteotomy at 
age of 23, infection at age of 
25, and recently progres­
sively painful hip. At opera­
tion a soft-tissue infection 
and a chronic osteomyelitis of 
the right femur were found. 
Cultures showed growth 
of Staphylococcus aureus. 
Technetium-99m-MDP 3 hr 
postinjection (A) and 1111n-IgG 
4 (B), 24 (C), 48 (D) hr post­
injection, and plain radio­
graph (E). The arrows indi­
cate corresponding areas.
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FIGURE 3
Patient 6 (27-yr-old female). Low-grade osteomyelitis after osteosynthesis for left tibial plateau fracture at age of 25. At surgery 
the diagnosis chronic osteomyelitis was confirmed. Cultures showed growth of Staphylococcus aureus and epidermidis. 
Technetium-99m-MDP 3 hr postinjection (A) and 1111n-IgG 4 (B), 24 (C) and 48 (D) hr postinjection. The arrows indicate 
corresponding areas.
mation. The impression at operation was, that bone, 
articular and soft-tissue involvement was predicted cor­
rectly by the 11‘In-IgG scintigraphy.
In three out of 25 patients, clinically suspected of 
having chronic infectious bone disease (Nos. 16, 17, 
and 18) no cultures were obtained. These patients had 
a recent history of recurrent fistulae, thus proving the 
infectious etiology of the bone disease. In all three 
patients, " 'In-IgG correctly localized the lesion and 
demonstrated the soft-tissue involvement in the region 
of the fistula.
In addition to the 25 cases stated above, we also 
studied seven patients not suffering from bone and joint 
infection. Figure 6 shows the ratio between the '" In -  
IgG uptake in the lesion and the corresponding area in 
the contralateral limb in five of these patients without 
evidence of infection. Patients 26 and 27 with recent 
tibial fractures (10 days and 3-wk-old, respectively) 
showed both positive skeletal and ‘"In-IgG scintigra­
phies. Patients 28 and 29 w'ith both ~6-mo-old fractures 
had a positive g9mTc-MDP bone scan. In these two 
patients, the 1 "In-IgG did not show the lesion, resulting 
in a ratio of — 1. Patient 30 showed evidence of a well- 
perfused soft-tissue tum our without osseous involve­
ment just above the knee. Initially, the tum our was well 
visualized by "'In-IgG, but over time no increasing 
'"In-IgG accumulation in the tum our could be noted. 
Histologic examination showed a haemangioma.
Patient 31, with clinically-cured sternal osteomyelitis, 
still showed a hot spot in the sternum at scintigraphy 
with g9mTc-MDP. Ind ium -111 -IgG scintigraphy did not 
reveal the lesion.
Figure 7 shows the scintigraphic images of Patient
32. This patient showed evidence of loosening of the 
right total-hip prosthesis. There was no evidence of 
septic loosening. The bone scintigram shows increased 
uptake in the right acetabular region. The '"In-IgG  
around the prosthesis was normal. Cultures taken at 
surgery showed no bacterial growth.
A relatively high intravascular activity of '"In-IgG  
can be noted up to 48 hr. Figure 8 demonstrates the 
blood clearance in three patients. The slow clearance of 
' "In-IgG resulted in a relatively high background activ­
ity at scintigraphy.
DISCUSSION
Our results indicate that " ‘In-IgG is able to identify 
the location and the extent of infectious bone and joint
FIGURE 4
Patient 22 (79-yr-old female). Progressive pain in lumbar spine, right shoulder, and right knee for 2 mo. Cultures taken by 
needle aspiration showed growth of Mycobacterium tuberculosis. Knee region: 99mTc-MDP 3 hr postinjection (A) and 111 In-IgG 
4 (B), 24 (C) and 48 (D) hr postinjection. The arrows indicate corresponding areas.
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disease. This is especially valuable in low-grade, chronic 
osteomyelitis.
Although WmTc-MDP skeletal scintigraphy is indis­
pensable for rapid localization of the site of the lesion 
and visualization of the osseous structures, little infor­
mation can be obtained about soft-tissue involvement 
and the actual extent and nature of the lesion, since it 
lacks specificity to discriminate between reactive in­
creased bone turn-over (i.e., bone remodelling) and 
actual inflammation (1,3,17,18).
In the literature, no definitive view has been reached 
on the value of 6 Ga scintigraphy and 1MIn-WBC im­
aging in patients with bone infections. Some authors 
reported about the usefulness of 67Ga scintigraphy in
chronic infectious bone disease (1,19). Others found a 
higher sensitivity of MIIn-WBC scintigraphy compared 
to ,7Ga imaging (2,17JO). It has been noted that 67Ga 
may accumulate in areas of increased bone turn-over, 
decreasing the specificity for infection (2,21,22). In rats 
with artificial muscle infection, the degree of 67Ga ac­
cumulation appeared to be modest compared to that of 
11‘In-IgG (4,5). In our limited experience ‘"In-IgG did 
not accumulate locally in the remodelling phase of 6- 
mo-old fractures and in an aseptic loosening of a total- 
hip prosthesis.
While '"In-W BC scintigraphy has proven to have a 
high diagnostic accuracy in acute infections, there is no 
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The ratio between the 111 In-IgG uptake 
in the lesion and the corresponding 
area in the contralateral limb in five 
patients suffering from noninfectious 
bone disease.
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FIGURE 7
Norm al1111n-IgG scintigraphy. Patient 32 (female, 64 hr). Total hip prosthesis in both hips. Pain in right hip region for 6 mo. At 
surgery, loosening of the acetabular component of the right total hip prosthesis was found. Bacterial cultures remained sterile. 
Technetium-99m-MDP 3 hr postinjection (A) and 1111n-IgG 4 (B), 24 (C) and 48 (D) hr postinjection. The arrows indicate 
corresponding areas.
patients, suffering from chronic osteomyelitis {2,3.6.19, 
20,23-25). In our study, ‘"In-IgG identified all patients 
suffering from chronic osteomyelitis.
A major advantage of '"In-IgG is the relatively easy 
and quick preparation of the radiopharmaceutical, 
when compared to " ‘In or g,mTc-HM-PAO WBC. 
When using WBC, 40-50 ml of blood has to be drawn 
carefully in order to obtain sufficient undamaged leu­
kocytes. Time-consuming, complex, and costly isola­
tion and labeling techniques are required ( 7,8). Whereas 
the preparation of " ‘In-WBC in our department re­
quires at least 2.5 hr, labeling of the IgG-DTPA conju­
gate with ‘ "In  takes only 10 min. In addition, a constant 
quality of ‘"In-IgG is guaranteed. Whereas many 
smaller nuclear medicine departments have problems 
with the proper labeling of leukocytes with ’"In, every 
department should be able to prepare " ‘In-IgG when 
the IgG-DTPA conjugate is available on the shelf. In 
view of the recent discussion between Mock et al. and
Hanna et al., the utility of labeling WBC with ,,gmTc 
colloid in fu ll  blood remains to be established (9-11).
Since oxine is a cytotoxic agent and " 'In  may cause 
radiation damage to long-living T-lymphocvtes, the 
" ‘In-oxine dose in labeling WBC is limited (26). As a 
consequence, relatively long imaging times are neces­
sary to obtain adequate images. In dogs, '"In-W BC and 
,gmTc-HM-PAO WBCs identified recent, artificially in­
flicted osteomyelitis in the appendicular skeleton 
equally well. Whether infection in the axial skeleton 
can be adequately detected remains to be established 
(27). Furthermore, it needs to be clarified whether a 
time span of 24 hr is sufficient to detect low-grade 
osteomyelitis with l,WmTc-labeled WBC scintigraphy.
One advantage of " 'In-W BC over '"In-IgG is the 
relatively fast blood clearance of '"In-W BC, resulting 
in a low background activity. This leads to a relatively 
good target-to-background ratio when '"In-W BC ac­
cumulation is present. However, the relatively high
FIGURE 8
The blood clearance of 1111n-IgG in 
three patients. The activity in the blood 
sample taken after 2 min is denomi­
nated as 100%. TIME (hours)
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background activity of 1 "In-IgG, even after 24 and 48 
hr, does not significantly interfere with image interpre­
tation. In the majority of patients, the best quality 
images were obtained 48 hr postinjection. However, the 
focus of infection could very well be delineated after 24 
hr. The images obtained 48 hr postinjection, were nec­
essary in some cases to establish the diagnosis of low- 
grade osteomyelitis and helped to discriminate between 
hypervascular status and accumulation of '"In-IgG. 
This differentiation is not relevant in most patients. 
Imaging up to 24 hr postinjection is in most cases 
sufficient. Thus, with regard to the half-life of the 
radionuclide, IgG imaging with UMmTc would be possi­
ble.
We are currently comparing the utility of 1 "In-WBC 
and ‘"In-IgG. Results in the first 16 patients, who were 
investigated with both techniques, suggest that ‘"In- 
IgG is at least as potent as " 'In-W BC in revealing an 
inflammatory lesion. However, compared to ' 1 'In-WBC 
a higher degree of uptake in a lesion can be noted when 
using 1 "In-IgG.
Since many patients in the study also received an 
injection of 99mTc-MDP shortly before the " 'In-IgG 
administration, high standard dosimetry was not pos­
sible. Preliminary data suggest that the radiation burden 
to any organ after the administration of 75 MBq '" In -  
IgG is far less than 50 mGy (5 rad). This is in agreement 
with other reports (13). Further studies are in progress. 
Intravenous IgG preparations in gram doses have been 
a safe therapeutic agent for years. The injection of 1 mg 
of radiolabeled IgG did not produce any clinical or 
biochemical side effects. For these reasons, " 'In-IgG 
can be regarded as a safe radiopharmaceutical (13,28).
The mechanism of IgG uptake at the inflammation 
site has not been fully elucidated yet. On the basis of 
experiments, using Fab, F(ab)2 and Fc fragments of the 
complete IgG molecule, it has been suggested that the 
Fc-portion of IgG is responsible for the concentration 
at the inflammation site (4,12). Recently, enhanced 
vascular permeability followed by macromolecular en­
trapment in the connective tissues was reported as a 
possible explanation for IgG accumulation (29).
With ‘"In-IgG, no definite discrimination is possible 
between infectious and sterile inflammation. In our 
study, this is demonstrated by the positive '"In-IgG 
scintigraphy in patients with a hematoma, sterile ar­
thritis, and recent fractures. This also applies to '" In -  
WBC scintigraphy (3,24,30-32). In case of chronic 
osteomyelitis, this is of minor importance, since a sterile 
inflammatory process seems unlikely in an area with 
recurrent infections. O f major importance is differen­
tiation between increased bone turn-over (due to repair 
process) and persisting infection.
Only 3 out of 32 patients were using antibiotics at 
the time of imaging. Therefore, no conclusions can be 
drawn regarding the effect of antibiotics on the outcome
of ‘"In-IgG scintigraphy. Data in the literature suggest 
little influence of an antibiotic regimen on the outcome 
of IgG scintigraphy (4).
Fischman et al. reported the usefulness of serial 1 "In- 
IgG scintigraphy in, for example, inflammatory bowel 
disease to assess the cure of the infection (4,13). 
Whether this holds true for the assessment of cure of 
infections of bone and joint will be the object of further 
studies. In our study, a patient with cured sternal osteo­
myelitis showed a negative ' 1 ‘In-IgG scintigraphy. Also, 
the specificity of ' ‘1 In-IgG imaging in skeletal infections 
has to be determined.
We conclude that with " 'In-IgG a safe, easily pre­
pared radiopharmaceutical has become available. We 
have obtained promising results with regard to the 
capability o f 1 "In-IgG scintigraphy to localize infectious 
bone and joint disease. This property is especially val­
uable for the investigation of low-grade, chronic osteo­
myelitis.
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